Sildenofil in Persistent Pulmonary Hypertension in Newborns
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study hopes to evaluate the effectiveness of early combined use of Sildenafil and nitric
oxide (iNO) in newborns with Persistent pulmonary hypertension (PPHN) and or hypoxemic
respiratory failure and assess whether this would improve oxygenation, improve time on
mechanical ventilation for these babies and also prevent rebound hypoxic episodes.